Skip to main content

    Medium & small size LCD business integration by Innovation Network Corporation of Japan (creation of Japan Display)

People

川合 弘造

Kozo’s anti-trust/competition practice covers every area of the practice, i.e., violation cases such as cartel and unilateral conduct, merger regulations, and compliance to prevent violations of Japanese and foreign competition laws. Kozo continues to be recognized by international law journals as one of the top practitioners in Japan in the area of competition law. He has handled large scale international cartel cases and has contributed to the realization of prominent merger regulations. In the area of international trade law, Kozo is widely recognized as a pioneer of trade law practice in Japan and has advised both the private sector and governmental agencies. He has been involved in most of the trade remedy investigations, such as those for the imposition of anti-dumping duties and subsidy countervailing duties as counsel to Japanese and foreign clients, and in some overseas trade remedy investigations to defend Japanese clients. In addition, Kozo’s practice covers international disputes, corporate crisis management, and regulatory investigations.

藤本 欣伸

Yoshinobu was promoted to partner in 1999. He has experience in NP loans, real estate transactions, and equity investment cases dealing with foreign capital funds and companies. In addition to domestic M&A and business integration cases, he has recently been engaged in many M&A and JV cases by Japanese corporations in the USA, Europe, and Asian countries. He has advised Japanese corporations on lawsuits in the USA and other overseas countries, and has extensive experience in the dispute settlement and risk management fields. He has won many awards in the Corporate/M&A, Private Wealth and Healthcare fields from business law reviews, such as Chambers Global and The Legal 500 Asia-Pacific.

伊達 隆彦

Takahiko handles a wide range of domestic and international M&A transactions, general corporate matters, and labor matters. In particular, he has extensive experience in private equity fund investments, cross-border transactions (mainly in Europe and the U.S.), as well as TMT and pharmaceutical industry-related M&A transactions. Regardless of the difficulty or complexity of a case, his policy is to respond in a flexible, appropriate, and timely manner in accordance with his clients’ needs and expectations. He is also actively involved in D&I activities and pro bono work.